The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP4255398
WO Application Number:
EP2021083654
Type:
European Patent Granted for NL
Status:
Deemed not to be granted according to art. 52.4a or 52.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP21819877.8
WO Publication Number:
WO2022117594
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Poland (PL)
Publications:
Dates
Filing date:
30/11/2021
Grant date:
07/08/2024
EP Publication Date:
11/10/2023
WO Publication Date:
09/06/2022
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
07/08/2024
EP B1 Publication Date:
07/08/2024
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
29/11/2041
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
07/08/2024
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
07/08/2024
Name:
Adamed Pharma S.A.
Address:
Pienkow ul. Mariana Adamkiewicza 6A, 05-152 Czosnow, Poland (PL)
From:
07/08/2024
Name:
Adalvo Limited
Address:
Malta Life Science Park
Building 1 Level 4, San Gwann, SGN 3000, Malta (MT)